[Skip to Content]
[Skip to Content Landing]
Medical News & Perspectives
May 18, 2005

NIH Panel Tries to Clear Confusion, Spur Research on Managing Menopause

JAMA. 2005;293(19):2329-2331. doi:10.1001/jama.293.19.2329

Nearly 3 years after findings from the Women’s Health Initiative (WHI) threw a major wrench into menopausal hormone use, a panel convened by the National Institutes of Health has taken a first step toward determining safe, effective approaches in managing symptoms of menopause.

Panel chair Carol Mangione, MD, said confusion has flooded discussions of managing menopausal symptoms since the WHI findings showed that estrogen only and estrogen plus progestin therapy can increase the risk of coronary heart disease, thromboembolism, stroke, and breast cancer.